Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2310 - YKL-39 induces monocytes migration and angiogenesis and inversely correlates with metastasis in patients with breast cancer


11 Sep 2017


Poster display session


Translational Research;  Breast Cancer


Irina Mitrofanova


Annals of Oncology (2017) 28 (suppl_5): v573-v594. 10.1093/annonc/mdx390


I. Mitrofanova1, L. Tengfei2, M. Zavyalova3, N. Litviakov4, M. Buldakov5, N. Cherdyntseva5, J. Kzhyshkowska6

Author affiliations

  • 1 Laboratory Of Translational Cellular And Molecular Biomedicine, Tomsk State University, 634050 - Tomsk/RU
  • 2 Medical Faculty Mannheim,institute Of Transfusion Medicine And Immunology, University of Heidelberg, Mannheim/DE
  • 3 Department Of Pathological Anatomy, Siberian State Medical University, Tomsk/RU
  • 4 Laboratory Of Virusology, Tomsk Cancer Research Institute RAMS, Tomsk/RU
  • 5 Laboratory Of Molecular Oncology And Immunology, Tomsk Cancer Research Institute RAMS, Tomsk/RU
  • 6 Institute Of Transfusion Medicine And Immunology, German Red Cross Blood Service Baden-Württemberg – Hessen, Mannheim/DE


Abstract 2310


Human chitinase-like proteins are considered as biomarkers of cancer and chronic inflammation.YKL-39 is a unique member of chitinase-like protein family due to its presence only in humans but not in rodents both on gene and protein levels. However, its biological activity and association with tumor progression remains unknown.


YKL-39 expression and secretion in human monocytes-derived macrophages was measured by RT-PCR and ELISA. Monocyte migration was analyzed in a trans-well system. In vitro tube formation assay was performed using HUVEC cells.112 female patients with nonspecific invasive breast cancer of stage IIA-IIIC (T1-4N0-3M0) were included in the study. Confocal microscopy analysis was used to identify cell type expressing YKL-39 in tumor samples.YKL-39 expression level was measured by RT-PCR in tumor biopsy specimens.


Human monocytes-derived macrophages differentiated in the presence of IL4 and TGFbeta, but not IL4 alone, were found to express high levels of YKL-39 mRNA and protein. Purified YKL-39 significantly enhanced the migration of human CD14+monocytes by 1.9 fold (p 


TGFbeta is a key cytokine inducing production of YKL-39 in macrophages. YKL-39 stimulates critical for tumor progression processes: chemotaxis of monocytes and angiogenesis. However high levels of YKL-39 expression in tumor samples are predictive for metastatic-free survival in patients with breast cancer, suggesting that YKL-39 can program monocytes and newly growing vessels to inhibit metastatic spread.

This study was supported by grant RNF №14-15-00350.

Clinical trial identification

Legal entity responsible for the study

Tomsk State University, Tomsk, Russian Federation


Tomsk State University, Tomsk, Russian Federation. This study was supported by grant RNF №14-15-00350.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.